Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Current Taxes (2022 - 2025)

Historic Current Taxes for Sunshine Biopharma (SBFM) over the last 4 years, with Q2 2025 value amounting to $258158.0.

  • Sunshine Biopharma's Current Taxes rose 124.99% to $258158.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $258158.0, marking a year-over-year increase of 124.99%. This contributed to the annual value of $268276.0 for FY2024, which is 1053.56% down from last year.
  • Per Sunshine Biopharma's latest filing, its Current Taxes stood at $258158.0 for Q2 2025, which was up 124.99% from $228115.0 recorded in Q1 2025.
  • Sunshine Biopharma's 5-year Current Taxes high stood at $416245.0 for Q1 2023, and its period low was $201541.0 during Q3 2023.
  • Its 4-year average for Current Taxes is $276444.5, with a median of $254971.0 in 2024.
  • Within the past 5 years, the most significant YoY rise in Sunshine Biopharma's Current Taxes was 2651.07% (2024), while the steepest drop was 3874.5% (2024).
  • Quarter analysis of 4 years shows Sunshine Biopharma's Current Taxes stood at $373191.0 in 2022, then decreased by 19.65% to $299869.0 in 2023, then dropped by 10.54% to $268276.0 in 2024, then decreased by 3.77% to $258158.0 in 2025.
  • Its Current Taxes stands at $258158.0 for Q2 2025, versus $228115.0 for Q1 2025 and $268276.0 for Q4 2024.